AP NEWS

Molecular Cytogenetics Markets, 2022: Fluorescence In Situ Hybridization & Array-based Technology - Global Business Report 2018 - ResearchAndMarkets.com

November 16, 2018

DUBLIN--(BUSINESS WIRE)--Nov 16, 2018--The “Molecular Cytogenetics - Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets.

This report analyzes the worldwide markets for Molecular Cytogenetics in US$ Thousand by the following Technologies:

Fluorescence In Situ Hybridization Array-based Technology.

The report profiles 27 companies including many key and niche players such as:

Abbott Molecular (USA) Agilent Technologies, Inc. (USA) Applied Spectral Imaging (USA) Biological Industries (Israel) Bio-Rad Laboratories, Inc. (USA) Cytognomix, Inc. (Canada) CytoTest, Inc. (USA) F. Hoffmann-La Roche Ltd. (Switzerland) Illumina, Inc. (USA) Leica Biosystems Nussloch GmbH (Germany) Oxford Gene Technology (UK) PerkinElmer, Inc. (USA) SciGene Corporation (USA) Thermo Fisher Scientific, Inc. (USA)

Key Topics Covered:

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations

Data Interpretation & Reporting Level

Quantitative Techniques & Analytics

Product Definitions and Scope of Study

Definitions

Fluorescence In Situ Hybridization (FISH)

Select FISH Procedures in Use

3D-FISH

Cellular Compartment Analysis of Temporal Activity

Combined Binary Ratio-FISH

Cryo-FISH

Immuno-FISH

Quantum Dot-Conjugates-FISH

Array-based Technology

Array-based Comparative Genomic Hybridization (aCGH)

2. INDUSTRY OVERVIEW

Molecular Cytogenetics Technologies: An Introductory Prelude

Future Prospects Remain Favorable for Cytogenetics Technologies

Uptrend in Life Sciences R&D and Healthcare Spending Creates Fertile Environment

Northbound Trajectory in Med Tech Sector Generates Parallel Opportunities

Developed Regions: Key Revenue Contributors

Fast Paced Growth Projected in Developing Regions

Prevailing Economic Scenario Favors Market Expansion

3. KEY MARKET TRENDS & GROWTH DRIVERS

Critical Importance of Molecular Biology in Laboratory Processes: Cornerstone for Present & Future Growth

Advanced Molecular Biology Techniques Broaden the Scope of Cytogenetics Technologies

Array-based Technologies: Largest & Fastest Growing Market Segment

Transition from FISH to Array Based Technologies: The Ongoing Trend

Array-based CGH to Emerge as First Line Test for Clinical Diagnosis of Chromosomal Anomalies

Molecular Cytogenetics Find Increasing Penetration in Clinical Pathological Testing

Enhanced AP LIS: A Must to Keep Pace with Advancing Molecular Cytogenetic Testing

Impact of Shifting Focus of Biopharmaceuticals from Research to Development on Microarray Technology

Despite Proliferation of Array-based Methods, FISH Technology Continues to Find Favor

Next-Gen Sequencing Seeks Role in Cytogenetics Processes

Molecular Cytogenetics Greatly Benefit Cancer Prognosis

Diverse Applications of FISH Technology in Oncology

Opportunity Indicator: Global Cancer Incidence on the Rise

Increasing Significance of Cytogenetic Analysis in Genetic Disease Diagnosis

Proven Efficacy in Nucleic Acid Diagnostics Favors Market Growth

Expanding Role of Molecular Cytogenetics in Personalized Medicine

Demographics Spell Growth Opportunities

4. TECHNOLOGY OVERVIEW

A Preface to Cytogenetics

Basic Terms and Definitions in Molecular Biology

DNA and RNA

RNA (Ribose nucleic acid)

Chromosomes

Gene

Genotype

Phenotype

Haplotype

Karyotyping

Karyotype

Nick

Probe

Reporter Molecule

Copy Number

Copy Number Variation

Analysis of Copy Numbers Variations

Chromosomal Abnormalities in Human Beings

An Overview of Select Chromosomal Anomalies

Insertions

Deletions

Duplication

Rearrangement

5. COMPETITIVE LANDSCAPE

American Companies Dominate the Cytogenetics Technologies Market

Competition from European Vendors Remains Firm

Vendors Emphasize Collaborations

Select Cytogenetics Technology Collaborations Announced in the Recent Past

M&A Activity

Select Recently Finalized M&A Deals in the Cytogenetics Technologies Marketplace

5.1 Focus on Select Global Players

5.2 Product Launches

SciGene Introduces CytoBrite PLUS Slide Incubation System

ASI Unveils Updated GenASIs Platform

5.3 Recent Industry Activity

OGT Leverages Sysmex’s European Network to Sell Cytocell FISH Products

Roche Molecular Systems to Shut NimbleGen Facility

Sysmex to Acquire Oxford Gene Technology

GeneDx Joins Hands with UC Health for Molecular Testing Services

Empire Genomics Teams Up with KromaTiD for Oncology Diagnostics

CytoTest Expands Sales Team in Europe

Thermo Fisher Scientific Acquires Affymetrix

Agilent Inks Co-Marketing Agreement with Applied Spectral Imaging

Empire Genomics Expands Global Distribution Network

CytoTest and CapitalBio to Jointly Develop Advanced Molecular Diagnostic Solutions

6. GLOBAL MARKET PERSPECTIVE

By Technology

7. REGIONAL MARKET PERSPECTIVE

7.1 The United States

A. Market Analysis

The United States: Prime Market for Cytogenetics Technologies

aCGH Predominate the Technological Front in Molecular Cytogenetics

The Clinical Sector: A Potential Market Opportunity for Array-based Technologies

Revised ACMG Guidelines to Accelerate Use of aCGH Over FISH Technology

Established Role of FISH Technology in Cytogenetics Applications

FISH in Diagnosis of Bladder Carcinoma

FISH in Breast Cancer Diagnosis

Restraints for Oncology FISH Probes

IHC Tests Curtail FISH Demand

Ageing Population and Growing Incidence of Cancer & Lifestyle Diseases - Opportunity Indicators

Emphasis on Personalized Medicine & Companion Diagnostics Widens Scope

B. Market Analytics

7.2 Canada

Market Analysis

7.3 Japan

A. Market Analysis

Japan Offers Robust Opportunities

Demographics Favor Demand Expansion

B. Market Analytics

7.4 Europe

A. Market Analysis

A Mature yet Growing Market

Analysis by Region

Analysis by Technology

Cancer Statistics in Europe

B. Market Analytics

7.4.1 France

Market Analysis

7.4.2 Germany

Market Analysis

7.4.3 Italy

Market Analysis

7.4.4 The United Kingdom

Market Analysis

7.4.5 Spain

Market Analysis

7.4.6 Russia

Market Analysis

7.4.7 Rest of Europe

Market Analysis

7.5 Asia-Pacific

A. Market Analysis

Asia-Pacific Evolves as Fastest Growing Market

Analysis by Region

Analysis by Technology

Factors Driving Demand for Laboratory Technologies in Asia-Pacific: A Review

Growing Biotech Sector

Increased Access to Healthcare & Rising Healthcare Awareness

Proliferation of Medical Tourism

B. Market Analytics

7.5.1 China

A. Market Analysis

China - A Market Laden with Opportunities

FISH Technology in Clinical Diagnostics

B. Market Analytics

7.5.2 Rest of Asia-Pacific

A. Market Analysis

An Insight into the Indian Microarray Market

B. Market Analytics

7.6 Rest of World

Market Analysis

8. COMPANY PROFILES

Total Companies Profiled: 27 (including Divisions

Subsidiaries - 29)

The United States (20) Canada (1) Europe (6) Germany (2)The United Kingdom (1)Rest of Europe (3) Asia-Pacific (Excluding Japan) (1)

For more information about this report visit https://www.researchandmarkets.com/research/d2bwh9/molecular?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181116005145/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Genomics

KEYWORD:

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY GENETICS

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 11/16/2018 06:05 AM/DISC: 11/16/2018 06:05 AM

http://www.businesswire.com/news/home/20181116005145/en

AP RADIO
Update hourly